1140PDPhase I study of KN035, a novel fusion Anti-PD-L1 antibody administered subcutaneously in patients with advanced solid tumors in the USA

K P Papadopoulos, W Harb, N Lu,X Ma, Y He, L Yuan,M Fu,Y Lin, W Xu, X Wang, P Wang, T Xu, R Dong, J Gong

ANNALS OF ONCOLOGY（2018）

Cited 12|Views63

No score

Key words

advanced solid tumors,solid tumors,antibody,anti-pd-l

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined